I’m delighted to have picked up my required allocation of sub $2-05 shares this morning. An unexpected bonus as far as I’m concerned.
No need to submit $30k for a few weeks and wait to see what allocation I get.
Nothing has changed in the big scheme of things for me. Yes this CR provides a degree of unnecessary distraction and gives people much to chatter about but the fundamentals of NEU and the expectant Trofinetide trial results remain the same.
I think it’s natural to doubt the outcome after such a long incubation period. I personally will await the science. After all that’s the reason I’ve been invested in this for such a long time.
Best of luck for the coming ‘trade period’ and exciting weeks ahead.
NEU Price at posting:
$2.02 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)